FDA Announces Proposed Collection of Information for Adverse Event Reports

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, as part of its efforts to gather records and reports concerning experiences with approved new animal drugs, including adverse event reports.